Lv11
88 积分 2023-10-13 加入
Structure-Based Optimization of 2-Aminopyrimidine Derivatives aste MyeloidPotent Multi-target FLT3/CHK1/IRAK4 Inhibitors for Ac Leukemia
3小时前
已完结
摘要 A020：TLR10 作为调节头颈部鳞状细胞癌代谢和氧化还原稳态的关键先天免疫效应子
7个月前
已关闭
Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint
8个月前
已完结
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA-mutant ovarian cancer
9个月前
已完结
CHK1 inhibitor SRA737 在 PARP 抑制剂耐药和 CCNE1 扩增的卵巢癌中具有活性
9个月前
已完结
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer
9个月前
已完结
A phase I study of SRA737 (formerly known as CCT245737) administered orally in patients with advanced cancer
9个月前
已关闭
Apigenin alleviates inflammation as a natural IRAK4 inhibitor
10个月前
已完结
Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML
10个月前
已完结
DNA Replication Stress as a Hallmark of Cancer
10个月前
已完结
皖公网安备34019202002308
